Copley Scientific has announced the appointments of Jamie Clayton as Managing Director and Matthew Fenn as Head of Business Development. Clayton joined powder characterization specialist Freeman Technology in 2008 and then served as Freeman's Operations Director beginning in 2011. Fenn has extensive experience in inhaled drug delivery and was most recently Senior … [Read more...] about Copley Scientific names new Managing Director and Head of Business Development
People
Aerami Therapeutics names Lisa Yañez as CEO
Aerami Therapeutics has announced that its current Chief Operating Officer Lisa Yañez will succeed Steve Thornton as CEO, effective January 1, 2023. Thornton will continue as a member of the Board of Directors. Prior to joining Aerami in June 2022, Yañez was VP of Global Strategic Marketing at Acceleron Pharma and previously held marketing positions at United … [Read more...] about Aerami Therapeutics names Lisa Yañez as CEO
Glenn Mattes steps down as CEO of TFF Pharmaceuticals; Harlan Weisman named Interim CEO
TFF Pharmaceuticals, which develops dry powder inhalation products based on its thin film freezing technology, has announced that Glenn Mattes will step down as CEO and that he will be succeeded on an interim basis by Harlan F. Weisman. Mattes joined TFF in 2018. Weisman's experience includes a number of leadership roles at Johnson & Johnson, Centocor, Coronado … [Read more...] about Glenn Mattes steps down as CEO of TFF Pharmaceuticals; Harlan Weisman named Interim CEO
Warner C. Greene appointed President and CSO of InvisiShield Technologies
InvisiShield Technologies, which is developing a human antibody nasal spray designed to prevent SARS-CoV-2 infection, has announced the appointment of Gladstone Institute of Virology and Immunology founding director Warner C. Greene as President and Chief Scientific Officer. Greene will continue in his role at Gladstone Institutes, where he is Senior Investigator, … [Read more...] about Warner C. Greene appointed President and CSO of InvisiShield Technologies
Noveayr Therapeutics names Simon Manners as CEO, Darrell Baker as Chairman
OBG subsidiary Noveayr Therapeutics has announced the appointments of former AstraZeneca VP, Respiratory, Simon Manners as CEO and former GSK Senior VP, Respiratory, Darrell Baker as Chairman. Noveayr is the parent company of Pharmaserve NW, which offers contract development and manufacturing for a range of OINDPs, and aerosol pharmaceutical maker Ayrton Saunders. … [Read more...] about Noveayr Therapeutics names Simon Manners as CEO, Darrell Baker as Chairman
Avalyn Pharma names Lyn Baranowski as CEO
Avalyn Pharma, which is developing its AP01 pirfenidone inhalation solution for the treatment of idiopathic pulmonary fibrosis (IPF), has named Lyn Baranowski as CEO, succeeding Bruce Montgomery. Baranowski was most recently Chief Operating Officer of Altavant Sciences and has extensive experience in commercial and business roles at pharmaceutical companies, including … [Read more...] about Avalyn Pharma names Lyn Baranowski as CEO
Transpire Bio announces development deal with INTO and names new Chief Scientific Officer
Transpire Bio, which previously announced deals with Recipharm for development of four inhaled products, announced a new deal with INTO (Inhalation Together) for development of three additional inhaled products: TRB-5, TRB-6 and TRB-7. INTO is a partnership between DFE Pharma, Sterling, and Harro Höfliger that was formed earlier this year to provide early development … [Read more...] about Transpire Bio announces development deal with INTO and names new Chief Scientific Officer
William Schachtner and Axel Perlwitz join Transpire Bio
Transpire Bio, a start-up inhaled drug developer based in Florida, has announced the appointment of two more OINDP experts, naming William Schachtner as Chief Technical Operations Officer and Axel Perlwitz as Chief Regulatory Affairs Officer. Like Transpire CEO Xian-Ming Zeng and Chief Medical Officer Mark Lepore, both Schachtner and Perlwitz previously held positions … [Read more...] about William Schachtner and Axel Perlwitz join Transpire Bio
InCarda Therapeutics names Robert Lisicki as CEO
Inhaled flecanide developer InCarda Therapeutics has named former Arena Pharmaceuticals executive Robert Lisicki as CEO, succeeding Grace Colón who the company says "intends to pursue other leadership opportunities within the life science space" but will continue to consult for InCarda. In addition to having served as Chief Commercial Officer at Arena, Lisicki … [Read more...] about InCarda Therapeutics names Robert Lisicki as CEO
Badrul Chowdhury to join PMI as Chief Life Sciences Officer, Smoke-Free Products
Shortly after Savara announced the resignation of Badrul Chowdhury as its Chief Medical Officer, Philip Morris International (PMI) has announced the appointment of Chowdhury as PMI's new Chief Life Sciences Officer, Smoke-Free Products, effective in January 2023. Chowdhury, a former Director of the FDA's Division of Pulmonary, Allergy, and Rheumatology Products, will … [Read more...] about Badrul Chowdhury to join PMI as Chief Life Sciences Officer, Smoke-Free Products